Encore
Experience the talks from the NEI Psychopharmacology Congress and pre-conference Workshop again, or for the first time!
Select year: Available to guests!     lock
pre-conference workshop
NEI Psychopharmacology Congress
Applying Antipsychotic Pharmacokinetics to Best Dosing Practices: Depot Medications
Jonathan M Meyer, MD

The pharmacokinetic properties of a medication can be as important as its efficacy in determining how successful a treatment is. Pharmacokinetics are particularly important when switching to and maintaining long-acting injectable antipsychotics. In this presentation, Dr. Jonathan Meyer explains how to use the pharmacokinetic properties of long-acting injectable antipsychotics to guide decisions regarding the initiation and maintenance of dosing these agents.

CME credits: 1.25

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Lightning Round: Differential Diagnosis of Depressive States
Stephen M Stahl, MD, PhD

Several disorders, including bipolar depression, mixed depression, and pseudobulbar affect (PBA) often resemble, and are misdiagnosed as, major depressive disorder (MDD). Misdiagnosis of any of these disorders can result in less than optimal treatment for patients, and negative consequences. In this lecture, Dr. Stephen M. Stahl addresses evidence-based strategies to differently diagnose patients presenting in a depressive state with symptoms that resemble depression.

CME credits: 1.25

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Psychosis: Challenging Issues in Parkinson's Disease and Other Neurodegenerative Disorders
Jonathan M Meyer, MD

In this presentation, Dr. Jonathan Meyer discusses psychosis in the context of Parkinson's and Alzheimer's diseases. Strategies for managing these patients will also be explored.

CME credit: 1.00

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Emerging Treatment Options for Tardive Dyskinesia
Andrew J Cutler, MD

Tardive dyskinesia (TD) is an ongoing concern for patients treated with antipsychotics. Discontinuation of antipsychotic treatment may offer the best chance of TD remission; however, alternative strategies of TD management must be employed in patients who require continued antipsychotic therapy. In this presentation, Dr. Andrew Cutler discusses new strategies for treating and managing tardive dyskinesia.

CME credits: 1.25

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Somewhere Over the Rainbow: Recommendations for the Diagnosis and Treatment of Depressive Mixed States
Roger S McIntyre, FRCPC, MD

As many as 70% of patients may exhibit mixed features (subtle symptoms of (hypo)mania) during a major depressive episode. In this presentation, Dr. Roger McIntyre discusses the importance of identifying mixed features in patients with mood disorders as well as up-to-date strategies for managing depressive mixed states.

CME credits: 1.25

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Beyond Monoamines: Novel Approaches to Antidepressant Treatment
Andrew J Cutler, MD

Our understanding of the neurobiology of depression has increased in recent years, there is recognition that the neurobiological substrates of depression may go beyond monoaminergic circuits. In this presentation, Dr. Andrew Cutler provides an update on novel antidepressant treatments that are recently available or in development, including the mechanisms of action that are thought to underlie their potential antidepressant effects.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download